pyrazolanthrone has been researched along with Cachexia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrego, J; Attri, KS; Dasgupta, A; King, RJ; Mulder, SE; Murthy, D; Shukla, SK; Singh, PK | 1 |
1 other study(ies) available for pyrazolanthrone and Cachexia
| Article | Year |
|---|---|
JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia.
Topics: Animals; Anthracenes; Cachexia; Cell Line, Tumor; Female; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Pancreatic Neoplasms | 2020 |